Calvin Sandra
5 of 9 shown
The 5 most recent of 9 visible filings, newest first.
- Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER1,625 sharesOption exercise
- Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER1,250 sharesOption exercise
- Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER2,500 sharesOption exercise
- Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER$19,099Open-market sale
- Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER$50,278Open-market sale